Peptides Codex
Home
Enzymatically processed neuropeptide mixture

Cerebrolysin

Cerebrolysin is an experimental mixture of low-molecular-weight peptides and amino acids produced by enzymatic breakdown of purified pig brain protein. It is studied for neurotrophic effects and used by prescription in some countries, but is not approved in Canada or the United States.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
n/a
Class
Enzymatically processed neuropeptide mixture
Function
Studied for neurotrophic and neuroprotective signaling
Context
Prescription product in some countries; not approved in Canada or the US

A brain-derived peptide mixture at the center of neurotrophic research debate.

Also known as: FPF-1070 · cerebrolysin peptide mixture

Part of the Neuropeptides & signaling cluster

Overview

Cerebrolysin is an experimental mixture of low-molecular-weight peptides and amino acids produced by enzymatic breakdown of purified pig brain protein. It is studied for neurotrophic effects and used by prescription in some countries, but is not approved in Canada or the United States.

Source & context

Biological / chemical source: Peptides and amino acids derived from purified pig brain protein

Primary research or clinical context: Prescription product in some countries; not approved in Canada or the US

What cerebrolysin is

Cerebrolysin is not a single peptide but a standardized mixture of short peptides and free amino acids derived from pig brain protein by enzymatic processing. It is proposed to mimic aspects of endogenous neurotrophic factors, which is why no single sequence or residue count describes it.

Research context

It has been studied in neurodegenerative and neurological conditions such as dementia and stroke. Systematic reviews report mixed and sometimes null findings, including analyses that found no clear benefit in acute ischemic stroke. Evidence quality varies, so conclusions remain contested.

Availability and status

Cerebrolysin is prescribed in parts of Europe and Asia but is not an approved drug in Canada or the United States. This page is educational, summarizing the scientific discussion without offering dosing, sourcing, or treatment recommendations.

FAQ about Cerebrolysin

What is Cerebrolysin?+

Cerebrolysin is an experimental mixture of low-molecular-weight peptides and amino acids produced by enzymatic breakdown of purified pig brain protein. It is studied for neurotrophic effects and used by prescription in some countries, but is not approved in Canada or the United States.

Is Cerebrolysin an approved medicine?+

Cerebrolysin is discussed here as a research / educational topic. Prescription product in some countries; not approved in Canada or the US. This is not medical advice.

What is the typical length of Cerebrolysin?+

Cerebrolysin is not a classic amino-acid chain peptide in the same sense; see the profile for classification details.

Related peptides

References & further reading

  1. 1.Wikipedia — Cerebrolysin
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Cerebrolysin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.